Yersinia pestis infection natural history, complications and prognosis: Difference between revisions
Sergekorjian (talk | contribs) |
YazanDaaboul (talk | contribs) |
||
Line 24: | Line 24: | ||
! style="background: #4479BA; width: 550px;" | '''Septicemic Plague''' | ! style="background: #4479BA; width: 550px;" | '''Septicemic Plague''' | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" |* Black death: Gangrene of distal upper and lower extremities and tip of the nose due to small vessel thrombosis | |style="padding: 5px 5px; background: #DCDCDC;" | | ||
*Black death: Gangrene of distal upper and lower extremities and tip of the nose due to small vessel thrombosis | |||
*Disseminated intravascular coagulopathy (DIC) | *Disseminated intravascular coagulopathy (DIC) | ||
*Adult respiratory distress syndrome (ARDS) | *Adult respiratory distress syndrome (ARDS) | ||
Line 37: | Line 38: | ||
! style="background: #4479BA; width: 550px;" | '''Pneumonic Plague''' | ! style="background: #4479BA; width: 550px;" | '''Pneumonic Plague''' | ||
|- | |- | ||
|style="padding: 5px 5px; background: #DCDCDC;" |*Septicemia | |style="padding: 5px 5px; background: #DCDCDC;" | | ||
*Septicemia | |||
*Abscess formation | *Abscess formation | ||
*Cavitation | *Cavitation |
Revision as of 22:07, 25 July 2014
Yersinia pestis infection Microchapters |
Differentiating Yersinia Pestis Infection from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Yersinia pestis infection natural history, complications and prognosis On the Web |
American Roentgen Ray Society Images of Yersinia pestis infection natural history, complications and prognosis |
FDA on Yersinia pestis infection natural history, complications and prognosis |
CDC on Yersinia pestis infection natural history, complications and prognosis |
Yersinia pestis infection natural history, complications and prognosis in the news |
Blogs on Yersinia pestis infection natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Assistant Editors-In-Chief: Esther Lee, M.A.
Overview
If plague patients are not given specific antibiotic therapy, the disease can progress rapidly to death. About 14% (1 in 7) of all plague cases in the United States are fatal.
Prognosis
Despite being a treatable disease, plague is still associated with a high case fatality rate, often attributable to late recognition and inappropriate antibiotic therapy. Untreated bubonic plague has a case fatality of rate 50-60%, with proper identification and prompt treatment the case fatality decreases to around 7%.[1] Untreated septicemia or pneumonic plague is almost universally fatal if untreated early on. Even with proper therapy the latter may lead to mortality rates as high as 50%. [2]
Complications
Bubonic Plague |
---|
|
Septicemic Plague |
|
Pneumonic Plague |
|
References
- ↑ "Human plague: review of regional morbidity and mortality, 2004-2009". Wkly Epidemiol Rec. 85 (6): 40–5. 2009. PMID 20151494.
- ↑ Dennis DT, Mead PS. Yersinia species, including plague. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 7th ed. Philadelphia, Pa.: Elsevier Churchill-Livingstone; 2009:chap 229.
- ↑ Koirala J (2006). "Plague: disease, management, and recognition of act of terrorism". Infect Dis Clin North Am. 20 (2): 273–87, viii. doi:10.1016/j.idc.2006.02.004. PMID 16762739.